Please login to the form below

Not currently logged in
Email:
Password:

Kane & Finkel announces new European director

John Flaherty will handle pan-European clients for the healthcare comms agency

John Flaherty, Kane & Finkel, European Communications 

Kane & Finkel has brought in ApotheCom ScopeMedical's John Flaherty to take on the role of European director.

Based at the agency's London office, Flaherty will be responsible for delivering integrated, multi-channel campaigns for pan-European clients, while also developing new business in the region.

Commenting on his appointment, Flaherty said: “I am looking forward to the exciting developments Kane & Finkel has in progress and to bringing the expertise of a highly creative independent agency to clients in Europe.

“It is refreshing to be part of an agency that takes an entrepreneurial approach to marketing in the healthcare space, and I'm eager for the opportunities such thinking will certainly create.”

Flaherty has experience in strategic planning, advertising and branding, medical education, PR, market access and digital development; having held various leadership positions with GSW Worldwide, Lowe Healthcare, Sudler & Hennessey and Huntsworth Health.

During his career he has worked on a number of award-winning strategies and creative campaigns in prescription, device, diagnostic and OTC categories.

In addition, as director of communications for the UK's Health Education Authority, he also developed public health campaigns for AIDS, smoking cessation, childhood immunisation and heart disease.

John Kane, principal and managing director of Kane & Finkel, said: “John's agency management experience and his knowledge of the European market, allied with his business development success will help further establish Kane & Finkel in this important region.”

8th October 2012

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...